Ron Bentsur, Chairman & CEO at Nuvectis Pharma, Inc. (NVCT), bought 10,000 shares at $10.29 ($103K) on 2024-03-18, disclosed to the SEC on 2024-03-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.29 | 5,000 | $51K | 50.0% |
| 2 | $10.29 | 5,000 | $51K | 50.0% |
| Total | $10.29 avg | 10,000 | $103K | 100% |
| Filing → |
| NVCT | BUY | 2024-12-26 | $21K | — | Filing → |
| NVCT | BUY | 2024-11-18 | $98K | — | Filing → |
| NVCT | BUY | 2024-05-15 | $13K | — | Filing → |